Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 10 2019
Historique:
received: 04 06 2019
accepted: 25 09 2019
entrez: 18 10 2019
pubmed: 18 10 2019
medline: 3 11 2020
Statut: epublish

Résumé

Neovascular glaucoma (NVG) is a terminal severe complication in eyes with proliferative diabetic retinopathy (PDR), and PDR eyes with vitreous hemorrhage (VH) which undergo vitrectomy may have higher risk of postoperative NVG. The incidence and the prognostic factor of postoperative NVG after 25-gauge vitrectomy with advanced surgical options remain unclear. We retrospectively reviewed medical records of 268 eyes of 268 consecutive PDR patients with VH who underwent 25-gauge vitrectomy and 12 months follow-up at seven centers. Preoperative ocular factors (visual acuity, tractional retinal detachment, panretinal photocoagulation [PRP]), demographics and clinical factors (sex, age, diabetic duration, HbA1c, hypertension, anticoagulant medication, and kidney function), surgical procedures, and postoperative complications were compared between patients who developed postoperative NVG (9.3%) and those who did not. NVG eyes was significantly younger (P = 0.026), had shorter diabetic duration (P = 0.022), higher HbA1c (P = 0.028), absence of PRP (P = 0.039) and higher frequency of postoperative VH (P = 0.0075) than non-NVG eyes. Logistic regression analysis identified postoperative VH (P = 0.014), shorter diabetic duration (P = 0.029), and no PRP (P = 0.028) as prognostic factors for postoperative NVG. This multicenter study indicates that younger age, uncontrolled diabetes, no PRP, and postoperative VH are risk factors of post-vitrectomy NVG.

Identifiants

pubmed: 31619708
doi: 10.1038/s41598-019-51411-6
pii: 10.1038/s41598-019-51411-6
pmc: PMC6795876
doi:

Substances chimiques

Glycated Hemoglobin A 0
hemoglobin A1c protein, human 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

14858

Références

Curr Eye Res. 2017 Sep;42(9):1269-1272
pubmed: 28632410
J Glaucoma. 2013 Sep;22(7):572-6
pubmed: 22407392
Prog Retin Eye Res. 2007 Sep;26(5):470-85
pubmed: 17690002
Arch Ophthalmol. 1995 Sep;113(9):1144-55
pubmed: 7661748
PLoS One. 2017 Jun 29;12(6):e0180252
pubmed: 28662119
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6523-30
pubmed: 26447988
Retina. 2003 Dec;23(6):764-70
pubmed: 14707824
Invest Ophthalmol Vis Sci. 2012 Sep 21;53(10):6403-10
pubmed: 22899753
J Coll Physicians Surg Pak. 2014 Oct;24(10):736-9
pubmed: 25327917
Acta Ophthalmol. 2020 Jun;98(4):e434-e439
pubmed: 31674137
Surv Ophthalmol. 2004 Jul-Aug;49(4):437-45
pubmed: 15231400
Semin Ophthalmol. 2013 May;28(3):165-72
pubmed: 23697619
Curr Diab Rep. 2016 Oct;16(10):99
pubmed: 27612846
Diabetes Res Clin Pract. 2003 Aug;61(2):93-101
pubmed: 12951277
Doc Ophthalmol. 1994;87(3):223-32
pubmed: 7835192
Jpn J Ophthalmol. 2015 Sep;59(5):288-94
pubmed: 26202442
Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):863-871
pubmed: 28063082
Am J Ophthalmol. 2013 Jul;156(1):106-115.e2
pubmed: 23791371
Lancet. 2007 May 26;369(9575):1823-1831
pubmed: 17531891
N Engl J Med. 2005 Aug 25;353(8):839-41
pubmed: 16120866
Ophthalmology. 1981 Jul;88(7):583-600
pubmed: 7196564
Diabetes Care. 2003 Nov;26(11):2999-3005
pubmed: 14578230
Medicine (Baltimore). 2017 Mar;96(10):e6263
pubmed: 28272234
J Ophthalmol. 2019 Dec 11;2019:5304524
pubmed: 31885887
Lancet. 2010 Jul 10;376(9735):124-36
pubmed: 20580421

Auteurs

Kei Takayama (K)

Department of Ophthalmology, National Defense Medical College, Tokorozawa, 3598513, Japan.

Hideaki Someya (H)

Department of Ophthalmology, National Defense Medical College, Tokorozawa, 3598513, Japan.

Hiroshi Yokoyama (H)

Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya, 6638501, Japan.

Yoshihiro Takamura (Y)

Department of Ophthalmology, University of Fukui Faculty of Medical Sciences, Yoshida, 9101193, Japan.

Masakazu Morioka (M)

Department of Ophthalmology, University of Fukui Faculty of Medical Sciences, Yoshida, 9101193, Japan.

Seiji Sameshima (S)

Department of Ophthalmology, Kagoshima University, Kagoshima, 8900046, Japan.

Tetsuo Ueda (T)

Department of Ophthalmology, Nara Medical University, Kashihara, 6348522, Japan.

Shigehiko Kitano (S)

Diabetes Center, Tokyo Women's Medical University School of Medicine, Tokyo, 1628666, Japan.

Maki Tashiro (M)

Diabetes Center, Tokyo Women's Medical University School of Medicine, Tokyo, 1628666, Japan.

Masahiko Sugimoto (M)

Department of Ophthalmology, Mie University, Tsu, 5148507, Japan.

Mineo Kondo (M)

Department of Ophthalmology, Mie University, Tsu, 5148507, Japan.

Taiji Sakamoto (T)

Department of Ophthalmology, Kagoshima University, Kagoshima, 8900046, Japan.

Masaru Takeuchi (M)

Department of Ophthalmology, National Defense Medical College, Tokorozawa, 3598513, Japan. masatake@ndmc.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH